Lensar (LNSR) Debt Ratio (2019 - 2026)

Lensar's (LNSR) quarterly Debt Ratio came in at 0.08 in Q1 2026, down 87.09% on a QoQ basis from 0.58 in Q4 2019.

Lensar (LNSR) Debt Ratio (2019 - 2026) Analysis & Trends

Lensar (LNSR) has 2 years of Debt Ratio data on file, last reported at 0.08 in Q1 2026.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.08 in Q1 2026; TTM through Mar 2026 was 0.08, a N/A change from a year earlier, with the FY2019 full-year figure at 0.58, changed N/A from the prior year.
Debt Ratio for Q1 2026 stood at 0.08, down from 0.58 in the prior quarter.
Over the last five years, Debt Ratio for LNSR reached as high as 0.08 in Q1 2026 and fell as low as 0.08 in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	0.31
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	0.32
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	0.30
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	0.04
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	0.30
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	0.27
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	0.30
10	Lensar	70.05 Mn	72.73 Mn	6.38 Mn	0.08

Historic Data

Download Data

Date	Value
Mar 31, 2026	0.08
Dec 31, 2019	0.58